Syndecan-1 Predicts Outcome in Patients with ST-Segment Elevation Infarction Independent from Infarct-related Myocardial Injury

[1]  M. Frenneaux,et al.  Endothelial dysfunction and glycocalyx shedding in heart failure: insights from patients receiving cardiac resynchronisation therapy , 2019, Heart and Vessels.

[2]  H. Thiele,et al.  Impact of direct stenting on myocardial injury assessed by cardiac magnetic resonance imaging and prognosis in ST-elevation myocardial infarction. , 2019, International journal of cardiology.

[3]  H. Thiele,et al.  Combined Intrahospital Remote Ischemic Perconditioning and Postconditioning Improves Clinical Outcome in ST-Elevation Myocardial Infarction: Long-Term Results of the LIPSIA CONDITIONING Trial , 2019, Circulation research.

[4]  L. Räber,et al.  Pre-existing treatment with aspirin or statins influences clinical presentation, infarct size and inflammation in patients with de novo acute coronary syndromes. , 2019, International journal of cardiology.

[5]  J. Bakker,et al.  Prognostic relevance of serum lactate kinetics in critically ill patients , 2018, Intensive Care Medicine.

[6]  C. Hassager,et al.  Plasma Concentration of Biomarkers Reflecting Endothelial Cell- and Glycocalyx Damage are Increased in Patients With Suspected ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock , 2018, Shock.

[7]  P. Erne,et al.  Impact of cardiac rehabilitation referral on one-year outcome after discharge of patients with acute myocardial infarction , 2018, European journal of preventive cardiology.

[8]  G. Hindricks,et al.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.

[9]  H. Thiele,et al.  Optimized Prognosis Assessment in ST-Segment–Elevation Myocardial Infarction Using a Cardiac Magnetic Resonance Imaging Risk Score , 2017, Circulation. Cardiovascular imaging.

[10]  C. Lücke,et al.  Prognostic Significance of Remote Myocardium Alterations Assessed by Quantitative Noncontrast T1 Mapping in ST-Segment Elevation Myocardial Infarction. , 2017, JACC. Cardiovascular imaging.

[11]  L. Räber,et al.  Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarction , 2016, European heart journal.

[12]  Byoung Wook Choi,et al.  How to Develop, Validate, and Compare Clinical Prediction Models Involving Radiological Parameters: Study Design and Statistical Methods , 2016, Korean journal of radiology.

[13]  G. Schuler,et al.  Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial. , 2015, European heart journal.

[14]  Gareth Ambler,et al.  How to develop a more accurate risk prediction model when there are few events , 2015, BMJ : British Medical Journal.

[15]  G. Meneses,et al.  Syndecan-1 in Acute Decompensated Heart Failure--Association With Renal Function and Mortality. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[16]  G. Schuler,et al.  Impairment of the Endothelial Glycocalyx in Cardiogenic Shock and its Prognostic Relevance , 2015, Shock.

[17]  E. Chaikof,et al.  Syndecan-1 Modulates the Motility and Resolution Responses of Macrophages , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[18]  R. D. de Boer,et al.  Fibrosis Marker Syndecan-1 and Outcome in Patients With Heart Failure With Reduced and Preserved Ejection Fraction , 2014, Circulation. Heart failure.

[19]  T. Billiar,et al.  Selective roles for toll-like receptors 2, 4, and 9 in systemic inflammation and immune dysfunction following peripheral tissue injury , 2013, The journal of trauma and acute care surgery.

[20]  S. Pedersen,et al.  Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines , 2013, Critical Care.

[21]  Holger Thiele,et al.  Relation of circulating MicroRNA-133a concentrations with myocardial damage and clinical prognosis in ST-elevation myocardial infarction. , 2012, American heart journal.

[22]  Yimu Yang,et al.  The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis , 2012, Nature Medicine.

[23]  H. Oberleithner,et al.  Firewall function of the endothelial glycocalyx in the regulation of sodium homeostasis , 2012, Pflügers Archiv - European Journal of Physiology.

[24]  A. Maksimenko,et al.  No-Reflow Phenomenon and Endothelial Glycocalyx of Microcirculation , 2011, Biochemistry research international.

[25]  G. Schuler,et al.  Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. , 2010, Journal of the American College of Cardiology.

[26]  Nozomi Fukai,et al.  Syndecan-1: An Inhibitor of Arterial Smooth Muscle Cell Growth and Intimal Hyperplasia , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[27]  P. Carmeliet,et al.  Increased Expression of Syndecan-1 Protects Against Cardiac Dilatation and Dysfunction After Myocardial Infarction , 2007, Circulation.

[28]  J. Spaan,et al.  Endothelial Cell Glycocalyx Modulates Immobilization of Leukocytes at the Endothelial Surface , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[29]  E. Antman,et al.  TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation: An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy , 2000, Circulation.

[30]  T. Killip,et al.  Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. , 1967, The American journal of cardiology.

[31]  K. Mahaffey,et al.  ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation , 2012 .